Human papillomavirus-associated oropharyngeal carcinoma (HPV-OPC) is clinicopathologically distinct entity from the HPV-unassociated one (nHPV-OPC). This study aimed to determine the relationship between histological subtypes of OPC and HPV status for Japanese cases and to identify histological structures of HPV-OPC.
66 OPC cases were categorized into conventional squamous cell carcinoma (SCC) and the variants. Conventional SCC was subcategorized into keratinizing (KSCC), non-keratinizing (NKSCC), and hybrid SCC (HSCC). HPV status of all cases was determined using p16-immunohistochemistry and HPV-DNA ISH.
Two histological subtypes, NKSCC and HSCC, tended to be HPV-OPC and KSCC tended to be nHPV-OPC with statistical significance. Two histological structures, abrupt keratinization, defined in the text, and comedo-necrosis among non-maturing tumor island, were observed for 58.1% and 38.7% of HPV-OPC, and tended to exist for HPV-OPC with statistical significance.
This study showed the association of NKSCC/HSCC with HPV-OPC in Japanese cases, and two histological structures, abrupt keratinization and comedo-necrosis among non-maturing island, were considered characteristic histological features of HPV-OPC.
Human papillomavirus-associated oropharyngeal carcinomaNon-keratinizing squamous cell carcinomaAbrupt keratinizationComedo-necrosis among non-maturing island
Human papillomavirus (HPV)-associated oropharyngeal carcinoma (HPV-OPC) has been recognized as a distinct clinicopathologic entity of head and neck cancer
. HPV-OPC has been reported to be distinct from HPV-unassociated oropharyngeal carcinoma (nHPV-OPC) on a molecular, epidemiological, and clinical basis
[2, 3]. From a clinical perspective, HPV-OPC is likely to be more radio-/chemo-sensitive, with a longer recurrence-free period, more positivity in regional lymph nodes, and with better prognosis than nHPV-OPC
[4–7]. As for the pathological view, p53 overexpression/mutation are found at significantly lower frequency for HPV-OPC than for nHPV-OPC
In terms of histopathology, there have been several papers on some histological subtypes/variants that are more likely to be HPV-associated
[9–15]. For example, Chernock et al. reported that non-keratinizing SCC (NKSCC) and hybrid SCC (HSCC) were more likely to be HPV-positive than keratinizing SCC (KSCC)
[9, 10]. However, there has been no study using Japanese cases, or no study focusing on characteristic histopathological structures for HPV-OPC so far. In Japanese OPC cases, the impact of several risk factors other than HPV infection, such as tobacco/alcohol exposure, may be different from that in Western countries. For example, in Western countries, patients with HPV-OPC are reported to have less tobacco exposure but more marijuana exposure than those with nHPV-OPC
[3, 5]. It is important to see the tendency of histological subtypes of HPV-OPC in Japanese cases with the different background risk factors.
In this study, we classified our HPV-OPC and nHPV-OPC cases by histological subtypes and determined if there are some histological features of concern, in order to determine the specificity/sensitivity of NKSCC, KSCC, HSCC for HPV-OPC with Japanese OPC cases and to identify histological structures characteristic for HPV-OPC.
In this study, HPV status for each case was judged by p16 immunohistochemistry (IHC)/in situ hybridization (ISH). Although there have been studies which propose genomic amplification of human telomerase gene or C-MYC as helpful screening methods for HPV-associated cancer/high-grade lesions in cases of uterine cervix
[16, 17], a gold standard method for detecting HPV-associated OPC has not been established at present. Several studies have mentioned the reliability and accessibility of p16 IHC and ISH for HPV DNA
[18–21]. In this study, we used the combined detection method of HPV ISH and p16 IHC according to Singhi et al.
66 pathological specimens of previously untreated oropharyngeal carcinoma (OPC), of which 39 were biopsy and 27 were surgical specimens, were studied. All patients were treated in the Department of Otorhinolaryngology, Head and Neck Surgery, Juntendo University, between 2004 and 2012. All materials were obtained before chemo- or radiotherapy. The clinical data, including tobacco/alcohol exposure, tumor site, clinical stage, and HPV status of cases, are shown in Table
1. The HPV status was judged according to a previous study
. Briefly, we used the result of IHC for p16 and that of ISH for HPV-DNA as shown in our algorithm (Figure
1). For IHC of p16, the result was interpreted as positive when more than 70% of tumor cells showed intense levels of both nuclear and cytoplasmic/nuclear staining (Figure
2A). For ISH, cases were interpreted as positive if hybridization signals visualized as punctate dots were present in the nuclei of the squamous cells (Figure
2B). The methods of ISH and IHC for p16 are described below.
Clinical features of oropharyngeal SCCs
(n = 66)
(n = 31)
(n = 35)
aAge: mean and range in parenthesis are shown
bTobacco and alcohol: (-), never; (+), ever and current
cTumor site: Lat, lateral wall; Ant, anterior wall; Post, posterior wall; Sup, superior wall.
Assessment of histopathology of oropharyngeal SCC
The histopathological classification and assessment of the tumors were conducted using light microscopy by three of the authors (MF, YF, and AK), in a blinded manner and without knowledge of HPV status. Formalin-fixed, paraffin-embedded samples were cut into 4-um sections and stained with hematoxylin and eosin (H&E). One to 5 sections for each were reviewed. For the histological classification, we followed the definitions in the WHO classification/previous articles
[9–15, 22], briefly, (i) KSCC, defined as being entirely composed of mature squamous cells without areas of NKSCC morphology, as described below (Figure
3A), (ii) NKSCC, defined as forming sheets with pushing borders of hyperchromatic, non-maturing tumor cells (Figure
3B), (iii) HSCC, showing NKSCC morphology and containing areas of focal squamous maturation throughout the tumor (Figure
3C,D), (iv) basaloid SCC (Figure
3E), (v) lymphoepithelial carcinoma (Figure
3F), and (vi) papillary SCC (Figure
3G). When cases could not be classified into any of the above, these were categorized as unclassified SCC (Figure
3H). When there was a mixture of two histological types, such as NKSCC and basaloid SCC, the case was categorized as the variant in this study (hence, in this case, as basaloid SCC).
Since two histopathological features, (i) ‘abrupt keratinization’ and (ii) ‘comedo-necrosis among non-maturing tumor island’, were often seen in our OPC cases, but were usually not observed in our daily pathological practice for squamous cell carcinoma of any other organ/tissue, we carefully evaluated the existence of these two histological structures. Here, we defined (i) ‘abrupt keratinization’ as cancer pearl formation or evident squamous maturation among or peripheral to the non-maturing tumor cell nest (Figure
4A) and (ii) ‘comedo-necrosis among non-maturing tumor island’ as coagulative necrosis formed among non-keratinizing/non-maturing tumor cell nest (Figure
4B). The existence of each histological parameter of ‘abrupt keratinization’ or ‘comedo-necrosis among non-maturing tumor island’ was analyzed independently.
Immunohistochemistry (IHC) for p16
IHC for p16 was performed using 4-μm-thick tissue sections from formalin-fixed paraffin-embedded tissues and with DAKO EnVision™ + Kit (DAKO Corp., Carpenteria, CA) following the manufacturer’s instructions.
In situ hybridization (ISH) for high-risk HPV-DNA
For ISH, a catalyzed signal amplification method for biotinylated probes (DAKO GenPoint, Carpenteria, CA) was used. Briefly, 5-μm tissue sections underwent deparaffinization, heat-induced target retrieval in citrate buffer (DAKO Target Retrieval Solution, Carpenteria, CA), and digestion using Proteinase K (DAKO, Carpenteria, CA). Slides were subsequently hybridized with a biotinylated HPV16/18-type-specific probe (DAKO, Carpenteria, CA). Signal amplification was performed by consecutive application of streptavidin-HRP complex and biotinyl tyramide. Visualization of positive hybridization signals was performed by incubation with the chromogenic substrate diaminobenzidine. Interpretation of staining was performed without knowledge of p16 IHC positivity or tumor origin. In some cases where there was discordance between p16 IHC and HPV 16/18 status (i.e. in p16 IHC-positive, ISH-negative cases), we performed analysis with a more extended panel of ISH probes that included types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 (DAKO, Carpenteria, CA) in order to check for other high-risk HPV associations.
As controls, squamous cell carcinoma of the tonsil was hybridized with a positive control (Human DNA, DAKO, Carpenteria, CA) biotinylated DNA probe, and with a negative control (Plasmid DNA, DAKO, Carpenteria, CA) biotinylated DNA probe.
To determine the association of each of the histological subtypes/histological structures with HPV status, and to see the relationship of patients’ age (43-59/60-87) and sex (F/M) to histological subtypes of OPC, cross-tabulation analyses were performed using Fisher’s exact test. The statistical analyses were performed using PASW Statistics 18.0 (SPSS, Chicago, IL).
This study was approved by the ethics committee of Juntendo University School of Medicine.
Histopathological features of HPV-OPC
Among all the 66 OPC cases examined, 54 (81.8%) were categorized as conventional SCC, being subcategorized into 22 (33.3%), 21 (31.8%), and 11 (16.7%) cases of KSCC, NKSCC and HSCC [Table
2]. Both NKSCC and HSCC cases were much more likely to be HPV-OPC than KSCC (Fisher’s exact test, both with p < 0.01), with sensitivity/specificity of 65.2%/80.6% for NKSCC and 30.4%/87.1% for HSCC. On the other hand, the sensitivity/specificity for KSCC being predictive of nHPV was 67.7%/95.6%. There were no association statistically between patients’ age/sex and histological subtypes of HPV-OPC. The cases other than conventional SCC were basaloid, papillary, and lymphoepithelial SCC, and were found in 3 (4.5%), 2 (4.5%), and 2 (3.0%) OPC cases, respectively, and the former two variants were more frequently HPV-OPC [Table
Histological classification of oropharyngeal carcinomas
Abrupt keratinization, as defined above, was observed in 18/31 HPV-OPC cases (58.1%) and in 2/35 nHPV-OPC cases (5.7%). Comedo-necrosis among non-maturing tumor island was observed in 12/31 nHPV-OPC cases (38.7%) and in 1/35 of nHPV-OPC cases (2.9%). The existence of abrupt keratinization/comedo-necrosis among non-maturing tumor island was both statistically associated with HPV-OPC (Fisher’s exact test, both with p < 0.001) [Tables
Abrupt keratinization in oropharyngeal carcinomas
Number of cases
Comedo-necrosis among non-maturing tumor island in oropharyngeal carcinomas
Number of cases
The present study showed that most (87% of all cases and 90% of biopsy cases) OPC cases were conventional SCC, and were subcategorized into 36.7% KSCC, 31.7% NKSCC, and 18.3% HSCC, where NKSCC and HSCC were more likely to be HPV-OPC, and most KSCC was nHPV-OPC with statistical significance. These results for Japanese OPC cases are in accordance with those of Chernock et al.
. In the study by Chernock et al., they compared the frequency of each of the three subtypes and the result of ISH for HPV-DNA and p16 IHC, and their result of ISH seemed to be more similar to our present data than that of p16 IHC.
In the present Japanese study, no significant difference in clinical data, including risk factors, was seen between HPV-OPC and nHPV-OPC groups. In Western countries, patients with HPV-OPC have different epidemiological data including less tobacco exposure, more marijuana exposure, and lower age than those with nHPV-OPC
[3, 5]. It seems interesting that, despite the different clinical background, there are still similar tendencies of histological subtypes between Japanese and Western HPV-OPC.
A few researchers have reported the association of papillary, basaloid, and undifferentiated SCC (lymphoepithelial SCC) with HPV-OPC
[11–15]. In this study, there was also a tendency of the former two variants to be HPV-OPC, although with a small sample size.
When investigating the histopathological features of HPV-OPC, some histological structures were noteworthy. Abrupt keratinization, cancer pearl formation/squamous maturation in an abrupt fashion among non-mature tumor island, or at a peripheral site of tumor nest, were not usually observed in our daily pathological practice for squamous cell carcinoma of any other organ/tissue. Although comedo-necrosis is not rare in many carcinomas including keratinizing SCC, comedo-necrosis among non-maturing SCC cells is unusual. Hence, we analyzed whether these two structures are characteristic histological structures for HPV-OPC or not. This study suggested that these two histological structures, abrupt keratinization and comedo-necrosis among non-maturing tumor island, are very specific for HPV-OPC.
Our study showed that NKSCC and HSCC are statistically more likely to be HPV-associated carcinoma, while KSCC is statistically more likely to be nHPV-OPC, which was also true for Japanese patients. Two histological structures, abrupt keratinization and comedo-necrosis among non-maturing island, were considered to be very specific pathological structures for HPV-OPC.
Written informed consent was obtained from the patient for the publication of this report and any accompanying images.
Department of Otorhinolaryngology, Juntendo University
Department of Human Pathology, Juntendo University School of Medicine, Juntendo University
Marur S, D’Souza G, Westra WH, et al.: HPV-associated head and neck cancer: a virus-related cancer epidemic.Lancet Oncol 2010, 11:781–789.PubMedView Article
Gillison ML: Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.Semin Oncol 2004, 31:744–754.PubMedView Article
Gillespie MB, Rubinchik S, Hoel B, et al.: Human papillomavirus and oropharyngeal cancer: what you need to know in 2009.Curr Treat Options Oncol 2009, 10:296–307.PubMedView Article
Chen AM, Li J, Beckett LA, et al.: Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer.Laryngoscope 2013, 123:152–157.PubMedView Article
Fakhry C, Westra WH, Li S, et al.: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.J Natl Cancer Inst 2008, 100:261–269.PubMedView Article
Lindquist D, Romanitan M, Hammarstedt L, et al.: Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.Mol Oncol 2007, 1:350–355.PubMedView Article
Haraf DJ, Nodzenski E, Brachman D, et al.: Human papillomavirus and p53 in head and neck cancer: clinical correlates and survival.Clin Cancer Res 1996, 2:755–762.PubMed
Chernock RD, El-Mofty SK, Thorstad WL, et al.: HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome.Head Neck Pathol 2009, 3:186–194.PubMed CentralPubMedView Article
El-Mofty SK, Lu DW: Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients. A distinct clinicopathologic and molecular disease entity.Am J Surg Pathol 2003, 27:1463–1470.PubMedView Article
Jo VY, Mills SE, Stoler MH, et al.: Papillary squamous cell carcinoma of the head and neck. Frequent association with human papillomavirus infection and invasive carcinoma.Am J Surg Pathol 2009, 33:1720–1724.PubMedView Article
Carpenter D, El-Mofty SK, Lewis JS Jr: Undifferentiated carcinoma of the oropharynx: a human papillomavirus – associated tumor with favorable prognosis.Mod Pathol 2011, 24:1306–1312.PubMedView Article
Singhi AD, Stelow EB, Mills SE, et al.: Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma.Am J Surg Pathol 2010, 34:800–805.PubMedView Article
Chernock RD, Lewis JS, Zhang Q, et al.: Human papillomavirus-positive basaloid squamous cell carcinoimas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma.Hum Pathol 2010, 41:1016–1023.PubMedView Article
Begum S, Westra WH: Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status.Am J Surg Pathol 2008, 32:1044–1050.PubMedView Article
Liu H, Liu S, Wang H, et al.: Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.Diagn Pathol 2012, 7:147.PubMed CentralPubMedView Article
Chen S, Yang Z, Zhang Y, et al.: Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.Diagn Pathol 2012, 7:40.PubMed CentralPubMedView Article
Ukpo OC, Flanagan JJ, Ma XJ, et al.: High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlated with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.Am J Surg Pathol 2011, 35:1343–1350.PubMedView Article
Singhi AD, Westra WH: Comparison of human papillomavirus in situ hybridization and p16 immunhistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience.Cancer 2010, 116:2166–2173.PubMed
Smeets SJ, Hesselink AT, Speel EJM, et al.: A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.Int J Cancer 2007, 121:2465–2472.PubMedView Article
Begum S, Gillison ML, Ansari-Lari MA, et al.: Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin.Clin Cancer Res 2003, 9:6469–6475.PubMed
Cardesa A, Gale N, Nadal A, Zidar N: Squamous cell carcinoma. In World Health Organization Classification of Tumours: Pathology & Genetics. Head and Neck Tumours. Edited by: Barnes L, Eveson JW, Reichart P, Sidransky D. Lyon: International Agency for Research on Cancer; 2010:118–121.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.